You are here

Division of Rheumatology

Name: Division of Rheumatology
Address: 4032 Debrecen, Nagyerdei krt 98.
Phone number: (+36 52) 255-091 / (+36 52) 411-717 / 54945
Fax: (+36 52) 255-091
E-mail: reuma.titkarsagmed.unideb.hu
Website of the institution: http://www.rheumatology.hu/

Publication list

Uploaded publications:
855
Publications in DEA:
847
OA:
255
Date range:
1995-2024
2024
  1. Haugen, I., Felson, D., Abhishek, A., Berenbaum, F., Bierma-Zeinstra, S., Dziedzic, K., Edwards, J., Englund, M., Hermann-Eriksen, M., Herrero-Beaumont, G., Hill, C., Ishimori, M., Jonsson, H., Karjalainen, T., Leung, Y., Maheu, E., Mallen, C., Marshall, M., Moe, R., Ramonda, R., Ritschl, V., Ritt, M., Stamm, T., Szekanecz, Z., Giesen, F., Stadt, L., Meulen, C., Wittoek, R., Greibrokk, E., Laheij, H., Kloppenburg, M.: 2023 EULAR classification criteria for hand osteoarthritis.
    Ann. Rheum. Dis. [Epub ahead of print]2024.
    Journal metrics:
    D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  2. Khanna, D., Kramer, F., Höfler, J., Ghadessi, M., Sandner, P., Allanore, Y., Denton, C., Kuwana, M., Matucci-Cerinic, M., Pope, J., Atsumi, T., Becvar, R., Czirják, L., Langhe, E., Hachulla, E., Ishii, T., Ishikawa, O., Johnson, S., Riccieri, V., Schiopu, E., Silver, R., Smith, V., Stagnaro, C., Steen, V., Stevens, W., Szűcs, G., Truchetet, M., Wosnitza, M., Distler, O.: Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
    RHEUMATOLOGY. [Epub ahead of print]2024.
    Journal metrics:
    D1 Pharmacology (medical) (2023)
    D1 Rheumatology (2023)
  3. Szűcs, G., Szekanecz, Z., Szamosi, S.: Can we define difficult-to-treat systemic sclerosis?.
    Expert Rev. Clin. Immunol. [Epub ahead of print]2024.
    Journal metrics:
    Q2 Immunology (2023)
    Q2 Immunology and Allergy (2023)
  4. Gulyás, A., Pinczés, L., Mátyus, J., Végh, E., Bedekovics, J., Tóth, J., Barna, S., Hunya, Z., Szabó, I., Gazdag, A., Illés, Á., Magyari, F.: Case report: targeted treatment strategies for Erdheim-Chester disease.
    Front Oncol. 14 1-6, 2024.
    Journal metrics:
    Q2 Cancer Research (2023)
    Q2 Oncology (2023)
  5. Zimmerman, D., Szekanecz, Z., Markovics, A., Rosenthal, K., Carambula, R., Mikecz, K.: Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.
    Front. Immunol. 15 1-13, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    Q1 Immunology and Allergy (2023)
  6. Taylor, P., Choy, E., Baraliakos, X., Szekanecz, Z., Xavier, R., Isaacs, J., Strengholt, S., Parmentier, J., Lippe, R., Tanaka, Y.: Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
    RHEUMATOLOGY. 63 (2), 298-308, 2024.
    Journal metrics:
    D1 Pharmacology (medical) (2023)
    D1 Rheumatology (2023)
  7. Tóth, E., Fagyas, M., Nagy, B., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
    GeroScience. 46 (2), 1561-1574, 2024.
    Journal metrics:
    Q1 Aging (2023)
    Q1 Cardiology and Cardiovascular Medicine (2023)
    D1 Complementary and Alternative Medicine (2023)
    Q1 Geriatrics and Gerontology (2023)
    D1 Veterinary (miscellaneous) (2023)
  8. Deibel, E., Carreira, P., Vonk, M., del Papa, N., Becvar, R., Guillén-Del-Castillo, A., Campochiaro, C., Poormoghim, H., Liem, S., Lazzaroni, M., Giollo, A., Mekinian, A., de Vries-Bouwstra, J., De Santis, M., Balbir Gurman, A., Mihai, C., De Luca, G., Moiseev, S., Zanatta, E., Foti, R., Rednic, S., Denton, C., Cutolo, M., Belloli, L., Airò, P., Garzanova, L., Moroncini, G., Inanc, M., Panopoulos, S., Tandaipan, J., Chatelus, E., Rosato, E., Kuwana, M., Yavuz, S., Alegre-Sancho, J., Smith, V., Szűcs, G., Henes, J., Rodríguez-Pintó, I., Atzeni, F., Spierings, J., Truchetet, M., Milchert, M., Brito de Araujo, D., Riemekasten, G., Bernardino, V., Martin, T., del Galdo, F., Vacca, A., Mendoza, F., Midtvedt, Ø., Murdaca, G., Santiago, T., Codullo, V., Cacciapaglia, F., Walker, U., Brunborg, C., Tirelli, F., Allanore, Y., Furst, D., Matucci-Cerinic, M., Gabrielli, A., Distler, O., Hoffmann-Vold, A.: Does the impact of COVID-19 on patients with systemic sclerosis change over time?.
    Arthritis Care Res. 76 (1), 88-97, 2024.
    Journal metrics:
    Q1 Rheumatology (2023)
  9. Geetha, D., Dua, A., Yue, H., Springer, J., Salvarani, C., Jayne, D., Merkel, P., Szűcs, G., ADVOCATE Study Group: Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.
    Ann. Rheum. Dis. 83 (2), 223-232, 2024.
  10. Szekanecz, Z., Buch, M., Charles-Schoeman, C., Galloway, J., Karpouzas, G., Kristensen, L., Ytterberg, S., Hamar, A., Fleischmann, R.: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
    Nat. Rev. Rheumatol. 20 (2), 101-115, 2024.
    Journal metrics:
    D1 Rheumatology (2023)
  11. Parodis, I., Girard-Guyonvarc'h, C., Arnaud, L., Distler, O., Domján, A., Van den Ende, C., Fligelstone, K., Kocher, A., Larosa, M., Lau, M., Mitropoulos, A., Ndosi, M., Poole, J., Redmond, A., Ritschl, V., Alexanderson, H., Sjöberg, Y., von Perner, G., Uhlig, T., Varjú, C., Vriezekolk, J., Welin, E., Westhovens, R., Stamm, T., Boström, C.: EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
    Ann. Rheum. Dis. 83 (6), 720-729, 2024.
    Journal metrics:
    D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  12. Szekanecz, Z., Szamosi, S., Benkő, S., Szűcs, G.: Monogénesen öröklődő és szerzett autoinflammatoricus betegségek.
    Orv. hetil. 165 (18), 683-697, 2024.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2023)
  13. Simon, D., Kacsándi, D., Karancsiné Pusztai, A., Soós, B., Végh, E., Kerekes, G., Czókolyová, M., Szamosi, S., Szűcs, G., Prohászka, Z., Németh, P., Berki, T., Szekanecz, Z.: Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: associations with Vascular Pathophysiology.
    Int. J. Mol. Sci. 25 (6), 1-14, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  14. Charles-Schoeman, C., Fleischmann, R., Mysler, E., Greenwald, M., Ytterberg, S., Koch, G., Bhatt, D., Wang, C., Mikuls, T., Chen, A., Connell, C., Woolcott, J., Menon, S., Chen, Y., Lee, K., Szekanecz, Z.: Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients.
    Arthritis Rheumatol. [Epub ahead of print]2024.
    Journal metrics:
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  15. Steiner, G., Van Hoovels, L., Csige, D., Gatto, M., Iagnocco, A., Szekanecz, Z.: Should ACR/EULAR criteria be revised changing the RF and ACPA scores?.
    Autoimmun. Rev. 23 (1), 1-5, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
  16. Zanatta, E., Moccaldi, B., Szűcs, G., Spagnolo, P.: Should we use nintedanib as early therapy in patients with SSc-ILD?.
    Autoimmun. Rev. 23 (1), 1-4, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
  17. Caporali, R., Germinario, S., Kacsándi, D., Choy, E., Szekanecz, Z.: Start RA Treatment - Biologics or JAK-Inhibitors?.
    Autoimmun. Rev. 23 (1), 1-4, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
  18. Szekanecz, Z.: Twenty shades of the mosaic of autoimmunity.
    Autoimmun. Rev. [Epub ahead of print]2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)